New curcumin analog, CCA-1.1, synergistically improves the antiproliferative effect of doxorubicin against T47D breast cancer cells
An improved compound of pentagamavunone-1 (PGV-1), chemoprevention-curcumin analog 1.1 (CCA-1.1), has been synthesized and proven to have antiproliferative effects against breast cancer cells. This study is designed to investigate the potency of CCA-1.1 alone and in combination with doxorubicin (Dox...
Saved in:
Main Authors: | Febri Wulandari (Author), Muthi' Ikawati (Author), Dhania Novitasari (Author), Mitsunori Kirihata (Author), Jun-ya Kato (Author), Edy Meiyanto (Author) |
---|---|
Format: | Book |
Published: |
Universitas Gadjah Mada,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tumour-suppressive effects of curcumin analogs CCA-1.1 and Pentagamavunone-1 in colon cancer: In vivo and in vitro studies
by: Febri Wulandari, et al.
Published: (2023) -
Preparation and Cytotoxic Evaluation of PGV-1 Derivative, CCA-1.1, as a New Curcumin Analog with Improved-Physicochemical and Pharmacological Properties
by: Rohmad Yudi Utomo, et al.
Published: (2022) -
Chemoprevention curcumin analog 1.1 promotes metaphase arrest and enhances intracellular reactive oxygen species levels on TNBC MDA-MB-231 and HER2-positive HCC1954 cells
by: Dhania Novitasari, et al.
Published: (2023) -
Synthesis and cytotoxicity of the boron carrier pentagamaboronon-0-ol for boron neutron capture therapy against breast cancer
by: Rohmad Yudi Utomo, et al.
Published: (2022) -
The Combination of Sorafenib and PGV-1 Inhibits the Proliferation of Hepatocellular Carcinoma Through c-Myc Suppression in an Additive Manner: In Vitro Studies
by: Dhania Novitasari, et al.
Published: (2024)